| Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array RA Eeles, AAA Olama, S Benlloch, EJ Saunders, DA Leongamornlert, ... Nature genetics 45 (4), 385-391, 2013 | 691 | 2013 |
| Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue CS Cooper, R Eeles, DC Wedge, P Van Loo, G Gundem, LB Alexandrov, ... Nature genetics 47 (4), 367-372, 2015 | 493 | 2015 |
| A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer S Guillaumier, M Peters, M Arya, N Afzal, S Charman, T Dudderidge, ... European urology 74 (4), 422-429, 2018 | 332 | 2018 |
| Mutational signatures of ionizing radiation in second malignancies S Behjati, G Gundem, DC Wedge, ND Roberts, PS Tarpey, SL Cooke, ... Nature communications 7 (1), 1-8, 2016 | 275 | 2016 |
| Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers EC Page, EK Bancroft, MN Brook, M Assel, MH Al Battat, S Thomas, ... European urology 76 (6), 831-842, 2019 | 245 | 2019 |
| Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets DC Wedge, G Gundem, T Mitchell, DJ Woodcock, I Martincorena, M Ghori, ... Nature genetics 50 (5), 682-692, 2018 | 244 | 2018 |
| Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma TJ Dudderidge, K Stoeber, M Loddo, G Atkinson, T Fanshawe, DF Griffiths, ... Clinical cancer research 11 (7), 2510-2517, 2005 | 234 | 2005 |
| High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series HU Ahmed, E Zacharakis, T Dudderidge, JN Armitage, R Scott, J Calleary, ... British journal of cancer 101 (1), 19-26, 2009 | 167 | 2009 |
| A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease A Amin Al Olama, Z Kote-Jarai, FR Schumacher, F Wiklund, SI Berndt, ... Human molecular genetics 22 (2), 408-415, 2013 | 164 | 2013 |
| Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion AS Ali, MC Hayes, B Birch, T Dudderidge, BK Somani European Journal of Surgical Oncology (EJSO) 41 (3), 295-299, 2015 | 148 | 2015 |
| Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry TT Shah, M Peters, D Eldred-Evans, S Miah, T Yap, NA Faure-Walker, ... European urology 76 (1), 98-105, 2019 | 143 | 2019 |
| Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. LC Brown, HU Ahmed, R Faria, AES Bosaily, R Gabe, RS Kaplan, ... Health technology assessment (Winchester, England) 22 (39), 1, 2018 | 132 | 2018 |
| The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography‐guided prostate biopsy in reducing infection rates: a systematic review A Cussans, BK Somani, A Basarab, TJ Dudderidge BJU international 117 (5), 725-731, 2016 | 105 | 2016 |
| What type of prostate cancer is systematically overlooked by multiparametric magnetic resonance imaging? An analysis from the PROMIS cohort JM Norris, LMC Echeverria, SRJ Bott, LC Brown, N Burns-Cox, ... European urology 78 (2), 163-170, 2020 | 95 | 2020 |
| Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience D Reddy, M Peters, TT Shah, M van Son, MB Tanaka, PM Huber, ... European Urology 81 (4), 407-413, 2022 | 85 | 2022 |
| A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study EK Bancroft, EC Page, MN Brook, S Thomas, N Taylor, J Pope, J McHugh, ... The Lancet Oncology 22 (11), 1618-1631, 2021 | 73 | 2021 |
| Evolution of the S outhampton E nhanced R ecovery P rogramme for radical cystectomy and the aggregation of marginal gains J Smith, ZW Meng, R Lockyer, T Dudderidge, J McGrath, M Hayes, B Birch BJU international 114 (3), 375-383, 2014 | 71 | 2014 |
| Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT FC Hamdy, D Elliott, S le Conte, LC Davies, RM Burns, C Thomson, ... Health Technology Assessment (Winchester, England) 22 (52), 1, 2018 | 55 | 2018 |
| Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22 JD Kelly, TJ Dudderidge, A Wollenschlaeger, O Okoturo, K Burling, ... PloS one 7 (7), e40305, 2012 | 54 | 2012 |
| Additional value of dynamic contrast-enhanced sequences in multiparametric prostate magnetic resonance imaging: data from the PROMIS study AES Bosaily, E Frangou, HU Ahmed, M Emberton, S Punwani, R Kaplan, ... European urology 78 (4), 503-511, 2020 | 52 | 2020 |
